Breaking News

TriRx Completes Acquisition of Elanco Manufacturing Facility

The Speke, UK facility offers capabilities to manufacture human health and animal health products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

TriRx Pharmaceutical Services, an international contract development and manufacturing organization (CDMO), has finalized and closed on its agreement with Elanco Animal Health to acquire the ownership and operations of its manufacturing site in Speke, UK. Elanco is one of the world’s leading animal health companies, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. The two companies agreed a two-facility sale and long-term s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters